In 2011, Stason Animal Health (SAH) was formed and currently offers a vertically integrated, value-added platform for drug development, manufacturing, distribution, marketing, and sales of pet health products into veterinary hospitals and retail drug stores. SAH is on-target as a leading developer, manufacturer and distributor of pet health products, including: FDA CVM approved prescription drugs, EPA approved flea and tick preventive products, and pet health supplements (OTC). SAH strives to become a leading player in the companion pet health marketplace.

For inquiries and more information, please contact:
Diana Wood VP, Corporate Development
diana.wood@stasonpharma.com